200 related articles for article (PubMed ID: 32401759)
1. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
[TBL] [Abstract][Full Text] [Related]
2. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Coelho RA; Alves GM; Figueiredo-Carvalho MHG; Almeida-Silva F; de Souza GR; Lourenço MCDS; Brito-Santos F; Amaral ACF; Almeida-Paes R
Mem Inst Oswaldo Cruz; 2022; 117():e220089. PubMed ID: 36102413
[TBL] [Abstract][Full Text] [Related]
3. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
Coelho RA; Brito-Santos F; Figueiredo-Carvalho MHG; Silva JVDS; Gutierrez-Galhardo MC; do Valle ACF; Zancopé-Oliveira RM; Trilles L; Meyer W; Freitas DFS; Almeida-Paes R
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
[TBL] [Abstract][Full Text] [Related]
5. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review.
da Silva Hellwig AH; Heidrich D; Zanette RA; Scroferneker ML
J Glob Antimicrob Resist; 2019 Mar; 16():108-114. PubMed ID: 30266638
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B.
Daboit TC; Massotti Magagnin C; Heidrich D; Czekster Antochevis L; Vigolo S; Collares Meirelles L; Alves K; Scroferneker ML
Mycoses; 2014 Feb; 57(2):116-20. PubMed ID: 23895037
[TBL] [Abstract][Full Text] [Related]
8. Effect of Melanin Biosynthesis Inhibition on the Antifungal Susceptibility of Chromoblastomycosis Agents.
Heidrich D; Pagani DM; Koehler A; Alves KO; Scroferneker ML
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0054621. PubMed ID: 33972246
[TBL] [Abstract][Full Text] [Related]
9. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
Yu J; Li R; Zhang M; Liu L; Wan Z
Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF
Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140
[TBL] [Abstract][Full Text] [Related]
11. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
[TBL] [Abstract][Full Text] [Related]
12. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Yang YP; Li W; Huang WM; Zhou Y; Fan YM
Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
[TBL] [Abstract][Full Text] [Related]
13. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Deng S; de Hoog GS; Badali H; Yang L; Najafzadeh MJ; Pan B; Curfs-Breuker I; Meis JF; Liao W
Antimicrob Agents Chemother; 2013 Apr; 57(4):1974-7. PubMed ID: 23380718
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
[TBL] [Abstract][Full Text] [Related]
17. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
Park SG; Oh SH; Suh SB; Lee KH; Chung KY
Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
[TBL] [Abstract][Full Text] [Related]
18. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
Daboit TC; Magagnin CM; Heidrich D; Castrillón MR; Mendes SD; Vettorato G; Valente P; Scroferneker ML
Mycopathologia; 2013 Aug; 176(1-2):139-44. PubMed ID: 23645135
[TBL] [Abstract][Full Text] [Related]
19. Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.
Calvo E; Pastor FJ; Salas V; Mayayo E; Capilla J; Guarro J
J Antimicrob Chemother; 2012 Mar; 67(3):666-70. PubMed ID: 22190608
[TBL] [Abstract][Full Text] [Related]
20. Chromoblastomycosis by Exophiala jeanselmei associated with squamous cell carcinoma.
Wang J; Zhu M; Wang P
J Mycol Med; 2021 Mar; 31(1):101105. PubMed ID: 33422739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
